Shares of Affymax Inc. (OTCMKTS:AFFY – Get Free Report) crossed above its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $0.00 and traded as high as $0.0016. Affymax shares last traded at $0.0016, with a volume of 3,000 shares traded.
Affymax Price Performance
The firm has a fifty day moving average price of $0.01.
About Affymax
Affymax, Inc was a biotechnology company focused on developing novel therapies for serious medical conditions. The company used drug-discovery and molecular engineering technologies to identify and advance pharmaceutical candidates, with an emphasis on treatments for hematology and related disorders.
Affymax’s principal product was peginesatide, an anemia treatment marketed in the United States under the brand name Omontys. The U.S. Food and Drug Administration approved Omontys in 2012 for the treatment of anemia associated with chronic kidney disease.
Featured Articles
- Five stocks we like better than Affymax
- Is Texas Instruments Setting Up for Its Next Big Breakout?
- Pegasystems’ Q3 Miss Exposed the Problem Standing Between AI and Cash Flow
- Lam Research’s Earnings Beat Wasn’t the Real Story—Its 2027 Outlook Was
- Tesla’s Flying-Car Hype Hits an Earnings Reality Check
Receive News & Ratings for Affymax Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Affymax and related companies with MarketBeat.com's FREE daily email newsletter.
